About Sierra Pharmaceuticals Limited.
Data last updated:
Sierra Pharmaceuticals Limited. is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 June 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL1999PLC100240. Its GSTIN is 06AAFCS0502B1Z6 (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.11 Lakh. It is led by directors including Veena Sharma and Anil Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 71 Church Lanesummon Bazar Bhogal, New Delhi, Delhi, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.38 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.53 Lakh (net margin 1.1%) and EBITDA of ₹4.24 Lakh (EBITDA margin 3.1%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 9% over five years.
The company is associated with 1 brand: Sierra Pharmaceuticals. As per MCA filings, the company has open charges of ₹99.2 Lakh on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sierrapharma.com.
Company details
Contact details
Sierra Pharmaceuticals Limited.'s registered office is in New Delhi, Delhi. Its website is sierrapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address71 Church Lanesummon Bazar Bhogal, New Delhi, Delhi, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sierra Pharmaceuticals Limited., buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sierra Pharmaceuticals Limited operates one associated brand: Sierra Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops effective medicines, treatments, and diagnostics for healthcare professionals and patients. | sierrapharma.com |
Business activity
The main business activity of Sierra Pharmaceuticals Limited is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sierra Pharmaceuticals Limited., buy the company report.
Financials of Sierra Pharmaceuticals Limited.
FY 2025 filings availableSierra Pharmaceuticals Limited. reported revenue of ₹1.38 Cr (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 11% fall in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sierra Pharmaceuticals Limited., buy the company report.
Board of directors of Sierra Pharmaceuticals Limited.
Sierra Pharmaceuticals Limited has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veena Sharma | Director | 01 Aug 2008 | 18 Years 2 Months | Current |
| Anil Sharma | Director | 14 Jun 1999 | 27 Years 4 Months | Current |
| Tanuj Sharma | Director | 01 Aug 2008 | 18 Years 2 Months | Current |
| Archna Sharma | Director | 14 Jun 1999 | 27 Years 4 Months | Current |
Peer comparison
Sierra Pharmaceuticals Limited. is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bioglaze Biotech Private Limited | ₹1.38 Cr (FY 2025) | 4.0% | Ambala Cantt, Haryana, India | |||
| Manspic Formulation Private Limited | ₹1.38 Cr (FY 2025) | -49.0% | Gwalior, Madhya Pradesh, India | |||
| Sierra Pharmaceuticals Limited.this company | ₹1.38 Cr (FY 2024) | ₹1.53 Lakh | 1.1% | -11.0% | New Delhi, Delhi, India | |
| Dekster Life Sciences Private Limited | ₹1.38 Cr (FY 2025) | 4.0% | Thrissur, Kerala, India | |||
| Vilexo Pharmaceuticals Private Limited | ₹1.37 Cr (FY 2024) | 7.0% | Delhi, India | |||
| Ranvin Healthcare Private Limited | ₹1.37 Cr (FY 2025) | 101.0% | Kanpur Nagar, Uttar Pradesh, India | |||
| Adegen Pharma Private Limited | ₹1.37 Cr (FY 2024) | 23.0% | Panchkula, Haryana, India | |||
| Mencure Pharmaceuticals Private Limited | ₹1.37 Cr (FY 2024) | 12.0% | Patna, Bihar, India |
To see the full peer comparison of Sierra Pharmaceuticals Limited., buy the company report.
Auditor
Sierra Pharmaceuticals Limited. is audited by DEEPAK & ARORA for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEEPAK & ARORA | FY 2020 | 003227N |
Shareholding
The shareholding of Sierra Pharmaceuticals Limited. is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sierra Pharmaceuticals Limited., buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Mar 2025 | 101082707 | Others | ₹9.2 Lakh | Open | |
| 09 Apr 2024 | 100918242 | Others | ₹50 Lakh | Open | |
| 08 Oct 2010 | 10247508 | Central Bank of India | ₹35 Lakh | Open | |
| 13 Jul 2002 | 90049201 | State Bank of India | ₹5 Lakh | Open |
To see the full charge records of Sierra Pharmaceuticals Limited., buy the company report.
Total charge records: 4 View all charges
Legal cases
Sierra Pharmaceuticals Limited. has 5 court cases on record: 4 filed by Sierra Pharmaceuticals Limited, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 0 |
| High courts | 1 | 1 | 0 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (3801-Matters Relating To Consumer Protection : Appeals u/s 23 of Consumer Protection Act, 1986.) | Filed by the company against Ansal Buildwell Ltd Through Mr. Gopal Ansal 118 Uff, Prakash Deed Building 7, Tolstoy Marg New Delhi-11000 ,New Delhi , Delhi and 8 others | Disposed |
| District court, Faridabad, Haryana | Court case (C S) | Filed by the company against Ms R.K. Laboratories Private Limited. | Disposed |
| District court, Faridabad, Haryana | Cheque dishonour complaint | Filed by the company against Chaya Pharmaceuticals | Disposed |
| District court, Faridabad, Haryana | Cheque dishonour complaint | Filed by the company against M/S Aditi Medical Agency | Disposed |
| High Court of Delhi | Court case (CO.PET.) | Filed against the company by M/S Utopian Remedies Pvt Ltd | Disposed |
To see the full case history of Sierra Pharmaceuticals Limited., buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sierra Pharmaceuticals Limited.; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sierra Pharmaceuticals Limited has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCS0502B1Z6 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sierra Pharmaceuticals Limited., buy the company report.
Recent activity
Sierra Pharmaceuticals Limited. has 6 board changes on record since 1999: 4 appointments and 2 cessations. The latest: Ajay Gupta ceased to be Director on 25 Sep 2009.
2 earlier events are in the company report.
Frequently asked questions
Sierra Pharmaceuticals Limited is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 June 1999 (27+ years old) and is registered under CIN U51397DL1999PLC100240.
Sierra Pharmaceuticals Limited has 4 current directors:
- Veena Sharma - Director
- Anil Sharma - Director
- Tanuj Sharma - Director
- Archna Sharma - Director
The latest financial statements of Sierra Pharmaceuticals Limited on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sierra Pharmaceuticals Limited is 06AAFCS0502B1Z6, registered in Haryana.
The CIN (Corporate Identification Number) of Sierra Pharmaceuticals Limited is U51397DL1999PLC100240. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sierra Pharmaceuticals Limited has 5 court cases on record: 4 filed by the company and 1 filed against it. Most are in the district courts.
Sierra Pharmaceuticals Limited was incorporated on 14 June 1999, making it 27+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sierra Pharmaceuticals Limited by revenue are Bioglaze Biotech Private Limited, Manspic Formulation Private Limited, Dekster Life Sciences Private Limited, Vilexo Pharmaceuticals Private Limited, Ranvin Healthcare Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ajay Gupta ceased to be Director on 25 Sep 2009. Sadhana Gupta ceased to be Director on 25 Sep 2009. Tanuj Sharma was appointed as Director on 01 Aug 2008. Sierra Pharmaceuticals Limited has 6 board changes on record in total.
Sierra Pharmaceuticals Limited can be reached through the website sierrapharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Sierra Pharmaceuticals Limited is at 71 Church Lanesummon Bazar Bhogal, New Delhi, Delhi, India.